SETDB1 modulates the TGFβ response in Duchenne muscular dystrophy myotubes
Science Advances · 2024
DOI: 10.1126/sciadv.adj8042 ↗Kurz gefasst
Fachartikel in der Zeitschrift Science Advances, 2024. Verfasst von Alice Granados und 14 weiteren Autor:innen. Beteiligte Einrichtung: Université Paris Cité, CNRS, Epigenetics and Cell Fate, UMR7216, F-75013 Paris, France. Hauptthemen laut MEDLINE: Muscular Dystrophy, Duchenne, Histone-Lysine N-Methyltransferase, Muscle Fibers, Skeletal, Transforming Growth Factor beta. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 42 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Overactivation of the transforming growth factor-β (TGFβ) signaling in Duchenne muscular dystrophy (DMD) is a major hallmark of disease progression, leading to fibrosis and muscle dysfunction. Here, we investigated the role of SETDB1 (SET domain, bifurcated 1), a histone lysine methyltransferase involved in muscle differentiation. Our data show that, following TGFβ induction, SETDB1 accumulates in the nuclei of healthy myotubes while being already present in the nuclei of DMD myotubes where TGFβ signaling is constitutively activated. Transcriptomics revealed that depletion of SETDB1 in DMD myotubes leads to down-regulation of TGFβ target genes coding for secreted factors involved in extracellular matrix remodeling and inflammation. Consequently, SETDB1 silencing in DMD myotubes abrogates the deleterious effect of their secretome on myoblast differentiation by impairing myoblast pro-fibrotic response. Our findings indicate that SETDB1 potentiates the TGFβ–driven fibrotic response in DMD muscles, providing an additional axis for therapeutic intervention.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Université Paris Cité, CNRS, Epigenetics and Cell Fate, UMR7216, F-75013 Paris, France.
- Sorbonne Université, Inserm, Institut de Myologie, Centre de Recherche en Myologie, Paris, France.
- Université Claude Bernard Lyon 1, CNRS UMR 5261, INSERM U1315, Institut NeuroMyoGène, Pathophysiology and Genetics of Neuron and Muscle (PGNM) Unit, 69008 Lyon, France.
ORCID-Profile: Alice Granados, Maeva Zamperoni, Maryline Moulin, Ekaterina Boyarchuk, Costas Bouyioukos, Elisa Negroni, Myriame Mohamed, Anne Bigot, Fabien Le Grand, Sonia Albini, Slimane Ait-Si-Ali
Zitieren
APA
Granados, A., Zamperoni, M., Rapone, R., Moulin, M., Boyarchuk, E., Bouyioukos, C., Del Maestro, L., Joliot, V., Negroni, E., Mohamed, M., Piquet, S., Bigot, A., Le Grand, F., Albini, S., & Ait-Si-Ali, S. (2024). SETDB1 modulates the TGFβ response in Duchenne muscular dystrophy myotubes. Science Advances. https://doi.org/10.1126/sciadv.adj8042
Vancouver
Granados A, Zamperoni M, Rapone R, Moulin M, Boyarchuk E, Bouyioukos C, et al. SETDB1 modulates the TGFβ response in Duchenne muscular dystrophy myotubes. Science Advances. 2024. doi:10.1126/sciadv.adj8042
BibTeX
@article{Granados2024,
author = {Granados, Alice and Zamperoni, Maeva and Rapone, Roberta and Moulin, Maryline and Boyarchuk, Ekaterina and Bouyioukos, Costas and Del Maestro, Laurence and Joliot, Véronique and Negroni, Elisa and Mohamed, Myriame and Piquet, Sandra and Bigot, Anne and Le Grand, Fabien and Albini, Sonia and Ait-Si-Ali, Slimane},
title = {SETDB1 modulates the TGFβ response in Duchenne muscular dystrophy myotubes},
journal = {Science Advances},
year = {2024},
doi = {10.1126/sciadv.adj8042}
}
EUVIMED